October 27, 2009 — Women with low- to intermediate-grade ductal carcinoma in situ (DCIS) with margins 3 mm or wider had an "acceptably low rate" of ipsilateral breast events 5 years after excision ...
Randomized phase II trial of preoperative lapatinib versus placebo in HER2-positive breast cancer. Background: The benefit of adding radiation therapy (RT) after excision of noninvasive carcinoma of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback